Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jang Ho Lee, Sehee Kim & Yeon-Mok Oh. (2023) A Prediction Scoring Model for the Effect of Withdrawal or Addition of Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 113-127.
Read now
Read now
Mario Cazzola, Josuel Ora, Luigino Calzetta, Paola Rogliani & Maria Gabriella Matera. (2022) Advances in inhaled corticosteroids for the treatment of chronic obstructive pulmonary disease: what is their value today?. Expert Opinion on Pharmacotherapy 23:8, pages 917-927.
Read now
Read now
Claudio Tantucci. (2021) Assessment and treatment of airflow obstruction in patients with chronic obstructive pulmonary disorder: a guide for the clinician. Expert Review of Respiratory Medicine 15:3, pages 385-391.
Read now
Read now
Articles from other publishers (6)
Yaya Gong & Hongyan Sun. (2022) Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation. International Journal of General Medicine Volume 15, pages 7459-7466.
Crossref
Crossref
Maryam Mohammadi–Araghi, Alireza Eslaminejad, Hossein Karegar-Borzi, Saeideh Mazloomzadeh & Fatemeh Nejatbakhsh. (2022) An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-8.
Crossref
Crossref
Elena V. Bolotova, Anna V. Dudnikova & Larisa V. Shulzhenko. (2022) Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 94:3, pages 396-400.
Crossref
Crossref
Stanislav Kotlyarov & Anna Kotlyarova. (2021) Molecular Mechanisms of Lipid Metabolism Disorders in Infectious Exacerbations of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 22:14, pages 7634.
Crossref
Crossref
Laura Pini, Laura Tiberio, Marianna Arici, Luciano Corda, Jordan Giordani, Elena Bargagli & Claudio Tantucci. (2021) Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in alfa-1 anti-trypsin deficiency-related COPD development?. Monaldi Archives for Chest Disease 91:4.
Crossref
Crossref
Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta & Maria Gabriella Matera. (2020) Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent. Drugs 80:17, pages 1799-1809.
Crossref
Crossref